Latest News & Features
Americas
The US Food and Drug Administration has approved a biosimilar application by pharmaceutical company Amgen, the fourth such product to be rubberstamped in the country. 26 September 2016
Americas
Law firm White & Case has hired Charles Larsen as a partner in its global intellectual property practice in Boston. 23 September 2016
Americas
Japan-based Otsuka Pharmaceutical has targeted three companies in a patent infringement lawsuit. 22 September 2016
Africa
Teva and Regeneron Pharmaceuticals have combined to develop and commercialise fasinumab, a novel nerve growth factor (NGF) antibody. 22 September 2016
Americas
Allergan has entered into an agreement to acquire Tobira Therapeutics for up to $1.7 billion. 22 September 2016
Americas
Sanofi has filed a complaint against Merck for allegedly infringing ten of its patents centring on the diabetes drugs Lantus and Lantus SoloSTAR. 21 September 2016
Americas
Pharmaceutical pay-for-delay deals worth less than around $10 million are unlikely to be challenged by the authorities in US courts, according to a speaker at the 2016 AIPPI World Congress in Milan. 20 September 2016
Biotechnology
In a session moderated by Dominic Adair of Bristows, panellists at the 2016 AIPPI World Congress in Milan yesterday discussed biosimilars substitution and interchangeability. 20 September 2016
Big Pharma
Sweden-based pharmaceutical research company BioInvent International has been granted additional patent protection for its BI-505 immune oncology programme for myeloma. 19 September 2016
Americas
A patent counsel at Eli Lilly has blasted the US Supreme Court for being lazy in its approach to assessing the patentability of gene-based sequencing. 19 September 2016